| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $73.0M | -6.4% | -37.8% |
| Cost of Revenue | $52.2M | -0.9% | -23.5% |
| Gross Profit | $20.8M | -17.8% | -57.6% |
| R&D Expense | $2.5M | -34.3% | -45.7% |
| SG&A Expense | $13.5M | -2.2% | -23.7% |
| Operating Income | -$3.3M | +35.1% | -119.2% |
| Pre-tax Income | -$5.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.7M | -10.1% | +32.8% |
| Accounts Receivable | $69.1M | -9.2% | -40.0% |
| Inventory | $43.0M | -17.4% | -9.3% |
| Current Assets | $278.9M | -10.2% | -8.8% |
| Total Assets | $491.4M | -6.4% | -37.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $16.7M | — | — |
| Capital Expenditures | $35.0M | — | — |
| Investing Cash Flow | -$35.0M | — | — |
| Financing Cash Flow | -$50.6M | — | — |
| Free Cash Flow | -$18.2M | — | — |
| +30.3% |
| +54.8% |
| Income Tax | $594K | -27.6% | +122.5% |
| Net Income | -$6.3M | +30.1% | +51.2% |
| EPS (Basic) | -$0.08 | +27.3% | +52.9% |
| EPS (Diluted) | -$0.08 | +27.3% | +52.9% |
| $70.7M |
| -9.4% |
| -32.2% |
| Long-term Debt | $70.1M | -9.3% | -25.2% |
| Total Liabilities | $185.7M | -14.2% | -32.5% |
| Stockholders' Equity | $305.7M | -1.0% | -39.8% |